Which pharmaceutical product innovation introduced the first GLP-1 receptor agonist for type 2 diabetes treatment, revolutionizing blood glucose management and later becoming a foundation for weight management therapies?

The medical industry continually evolves through product innovation, bringing revolutionary treatments to patients worldwide. This poll tests your knowledge about a significant pharmaceutical breakthrough that changed the treatment landscape for a common chronic condition. Understanding product innovations in medicine helps healthcare professionals appreciate the R&D journey and its impact on patient care. Can you identify this game-changing medical innovation?

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Byetta (exenatide) by Amylin Pharmaceuticals/Eli Lilly
Lantus (insulin glargine) by Sanofi
Januvia (sitagliptin) by Merck
Metformin XR by Bristol-Myers Squibb